Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20006788HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS20050635HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS20050286HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS20018566HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS20050919HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS20034063HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS20045082HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS44009720HTLV-1ENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS44033961HTLV-1ENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS44049462HTLV-1ENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TCGA Plot Options
Drug Information
GenePDE3A
DrugBank IDDB00922
Drug NameLevosimendan
Target IDBE0000436
UniProt IDQ14432
Regulation Typeinhibitor
PubMed IDs16116344
CitationsSzilagyi S, Pollesello P, Levijoki J, Haikala H, Bak I, Tosaki A, Borbely A, Edes I, Papp Z: Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone. J Cardiovasc Pharmacol. 2005 Sep;46(3):369-76.
GroupsApproved; Investigational
Direct ClassificationPhenylhydrazines
SMILESC[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1
Pathways
PharmGKBPA164749138
ChEMBLCHEMBL2051955